We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
THC invested $125M in seven ASC acquisitions and three de novo centers, nearing half its annual plan.
Tenet Healthcare says higher-acuity outpatient procedures are strengthening growth and profitability.
The next phase of Tenet Healthcare Corporation’s (THC - Free Report) growth is increasingly unfolding beyond its hospitals. Through United Surgical Partners International (“USPI”), Tenet is expanding its ambulatory surgery center (ASC) network to benefit from the healthcare industry's steady shift toward lower-cost outpatient care. As higher-acuity procedures continue shifting to outpatient settings, USPI is becoming an increasingly important driver of long-term growth.
That strategy is already translating into strong results. In the first quarter of 2026, USPI generated $484 million in adjusted EBITDA, up 6.1% year over year, while same-facility revenues increased 5.3%. The business also posted double-digit growth in outpatient joint replacements, reflecting rising demand for higher-acuity procedures. Despite weather-related disruptions, USPI delivered a stronger-than-expected quarter, underscoring the strength of the business.
Tenet is backing that momentum with continued investment. It invested $125 million during the quarter to acquire seven ASCs and open three de novo centers, completing nearly half of its planned annual investment. A healthy acquisition pipeline, coupled with reaffirmed full-year guidance, reflects confidence in USPI's long-term growth trajectory.
More importantly, USPI is helping reshape Tenet's portfolio. By expanding higher-acuity outpatient services, the company enables more complex procedures to be performed in lower-cost settings, supporting long-term growth and profitability. As the shift toward outpatient care continues, USPI is well positioned to remain a key driver of Tenet's long-term growth and shareholder value.
How Do Peers Compare?
Tenet is not alone in capitalizing on the shift toward outpatient care. Medical peers such as Surgery Partners, Inc. (SGRY - Free Report) and HCA Healthcare, Inc. (HCA - Free Report) are also expanding their outpatient surgery networks to meet growing demand for lower-cost, high-quality surgical care.
Surgery Partners continues to expand its ambulatory surgery center network through acquisitions, physician partnerships and a growing focus on higher-acuity procedures. SGRY's strategy reflects the increasing demand for outpatient surgical care and reinforces the long-term growth potential of the ASC market.
HCA Healthcare continues investing in ambulatory surgery centers and outpatient facilities while expanding higher-acuity service lines. HCA is also increasing capacity across its outpatient network to support future patient demand and long-term growth.
THC’s Price Performance, Valuation & Estimates
Shares of Tenet Healthcare have gained 8.6% over the past year compared to the industry's 4.3% decline over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, THC trades at a forward price-to-earnings ratio of 10.62X, up from the industry average of 9.06X. THCcarries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for THC’s 2026 earnings is pegged at $17.61 per share, implying a 4.9% jump from the year-ago period’s level.
View the Zacks #1 Rank List
Image: Bigstock
Beyond the Hospital Walls: Why USPI Is Becoming Tenet's Growth Engine
Key Takeaways
The next phase of Tenet Healthcare Corporation’s (THC - Free Report) growth is increasingly unfolding beyond its hospitals. Through United Surgical Partners International (“USPI”), Tenet is expanding its ambulatory surgery center (ASC) network to benefit from the healthcare industry's steady shift toward lower-cost outpatient care. As higher-acuity procedures continue shifting to outpatient settings, USPI is becoming an increasingly important driver of long-term growth.
That strategy is already translating into strong results. In the first quarter of 2026, USPI generated $484 million in adjusted EBITDA, up 6.1% year over year, while same-facility revenues increased 5.3%. The business also posted double-digit growth in outpatient joint replacements, reflecting rising demand for higher-acuity procedures. Despite weather-related disruptions, USPI delivered a stronger-than-expected quarter, underscoring the strength of the business.
Tenet is backing that momentum with continued investment. It invested $125 million during the quarter to acquire seven ASCs and open three de novo centers, completing nearly half of its planned annual investment. A healthy acquisition pipeline, coupled with reaffirmed full-year guidance, reflects confidence in USPI's long-term growth trajectory.
More importantly, USPI is helping reshape Tenet's portfolio. By expanding higher-acuity outpatient services, the company enables more complex procedures to be performed in lower-cost settings, supporting long-term growth and profitability. As the shift toward outpatient care continues, USPI is well positioned to remain a key driver of Tenet's long-term growth and shareholder value.
How Do Peers Compare?
Tenet is not alone in capitalizing on the shift toward outpatient care. Medical peers such as Surgery Partners, Inc. (SGRY - Free Report) and HCA Healthcare, Inc. (HCA - Free Report) are also expanding their outpatient surgery networks to meet growing demand for lower-cost, high-quality surgical care.
Surgery Partners continues to expand its ambulatory surgery center network through acquisitions, physician partnerships and a growing focus on higher-acuity procedures. SGRY's strategy reflects the increasing demand for outpatient surgical care and reinforces the long-term growth potential of the ASC market.
HCA Healthcare continues investing in ambulatory surgery centers and outpatient facilities while expanding higher-acuity service lines. HCA is also increasing capacity across its outpatient network to support future patient demand and long-term growth.
THC’s Price Performance, Valuation & Estimates
Shares of Tenet Healthcare have gained 8.6% over the past year compared to the industry's 4.3% decline over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, THC trades at a forward price-to-earnings ratio of 10.62X, up from the industry average of 9.06X. THCcarries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for THC’s 2026 earnings is pegged at $17.61 per share, implying a 4.9% jump from the year-ago period’s level.
Image Source: Zacks Investment Research
THC currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.